Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from PainChek Ltd ( (AU:PCK) ) is now available.
PainChek Ltd has appointed Nick Garofoli as the Head of Business Development for the USA, marking a strategic move to expand its presence in the American market. Garofoli’s extensive experience in the aged care and technology sectors is expected to enhance PainChek’s market entry and growth in the US, particularly as the company anticipates FDA clearance. His leadership is anticipated to strengthen strategic partnerships and improve care outcomes for older adults, aligning with PainChek’s mission to transform pain assessment and management.
More about PainChek Ltd
PainChek Ltd is a company specializing in the development of smart device-based pain assessment and monitoring applications. The company focuses on providing innovative solutions for pain management in various environments, particularly for individuals who cannot reliably self-report their pain. PainChek’s app combines AI-driven pain assessment tools with the Numerical Rating Scale to offer accurate and consistent pain assessments. The company has gained regulatory clearance in multiple countries and collaborates with over 1,800 aged care facilities globally.
Average Trading Volume: 1,229,226
Technical Sentiment Signal: Buy
Current Market Cap: A$77.36M
For an in-depth examination of PCK stock, go to TipRanks’ Stock Analysis page.